Special Report: Neuro-oncology
Part 1. Epidemiology, clinical evaluation, and diagnosis
Brian J. Williams, MD
Case Report: Complete Spinal Cord Injury
Emergency surgical cord decompression before functional paralysis can preserve function after spinal cord injury.
Reginald Lafleur, MD; Melissa Lafleur, MD; Steven Mandel, MD; and Jason A. Ellis, MD
Case Report: Hemichorea in a Woman With Diabetes
Nonketotic hyperglycemic hemiballism-hemichorea can present radiographically before clinical symptoms are seen.
Erin Fiedler, DO; and José Biller, MD, FAAN, FACP, FAHA
Challenge Case Report: Subacute Cognitive Decline
Margaret Yu, MD; Christian Sikorski, MD; Craig M. Horbinski, MD; and Rimas V. Lukas, MD
Neuromuscular Notes: Hereditary Neuropathy
It is becoming increasingly important to establish a molecular genetic diagnosis.
Trisha Multhaupt-Buell, MS, CGC; and Reza Sadjadi, MD
Imaging in Parkinson’s Disease
Imaging studies can differentiate Parkinson’s from other causes of parkinsonism.
Catherine L. Gallagher, MD
Early Clinically Unsuspected Alzheimer’s Disease
Biomarkers can be important tools for diagnosis.
Georgette A. Khoury, MSN, APRN-BC; and Ira J. Goodman, MD
Genomics to Gene Therapy in Neurology
Recent advances in neurogenomics are changing how we practice neurology.
William Renthal, MD, PhD
Utility of Skin Biopsy in Neuromuscular Disease
Intraepidermal nerve fiber density finding can help diagnose small fiber neuropathy.
David S. Saperstein, MD
Evaluation for elevated creatine kinase is a required skill for neurologists.
Nicholas J. Silvestri, MD; and Gil I. Wolfe, MD
Genetic Testing in Neuromuscular Disorders
Understanding ordering and interpretation of genetic tests is paramount for clinical management.
James P. Orengo, MD, PhD; and David R. Murdock, MD
Disclosing Risk Factors to Individuals Without Cognitive Impairment
Negative consequences of risk factor disclosure are likely to be most severe among people who are inadequately prepared to receive the information.
Joshua D. Grill, PhD
Alzheimer’s Disease Biomarkers
Amyloid, tau, neurodegeneration (ATN)—where do we go from here?
Serge Gauthier, CM, CQ, MD, FRCPC; and Pedro Rosa-Neto, MD, PhD
Brain Imaging in Differential Diagnosis of Dementia
Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.
Mathew R. Ayers, DO; Diana Svaldi, PhD; and Liana G. Apostolova, MD, MS
Neuropsychologic Assessment for Neurodegeneration
What is the value of neuropsychologic assessment in neurodegenerative diseases?
Jennifer Medina, PhD; and Sarah J. Banks, PhD, ABPP-CN
Dizziness and Vertigo
Part 1: Untangling the complexity of dizziness and vertigo requires a careful history.
Daniel R. Gold, DO; and Ari A. Shemesh, MD
Case Report: A Woman with Tinnitus and Tongue Atrophy
Glomus tumors, the great masquerader, have variable presentation and multiple treatment options.
John A. Boockvar, MD; Jason A. Ellis, MD; David J. Langer, MD; Steven Mandel, MD; Rafael A. Ortiz, MD; Asif Rahman; and Tejaswi D. Sudhakar
Case Report: Longitudinally Extensive Transverse Myelitis
The borderline of neuromyelitis optica and systemic lupus erythematosus.
Ylec Mariana Cardenas, MD; Lakshmi Leishangthem, MD; Aparna Prabhu, MD; David Roby, MD; Pooja SirDeshpande, MD; and Saman Zafar, MD
Seizure Detection and SUDEP Prevention
Seizure detection and alerting devices hold promise for preventing sudden death in epilepsy.
Daniel Friedman, MD, MSc; and Cassandra Kazl, MD